| 1 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Ustekinumab 
                
                    Ustekinumab
                
             💬
 | 
                
                    Ustekinumab
                
             | [16]  37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
 | 
| 2 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Tildrakizumab 
                
                    Tildrakizumab
                
             💬
 | 
                
                    Tildrakizumab
                
             | [2]  162 162, 271 💬
 | 
| 3 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Guselkumab 
                
                    Guselkumab
                
             💬
 | 
                
                    Guselkumab
                
             | [5]  37 37, 41, 51, 96, 97 💬
 | 
| 4 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Brazikumab 
                
                    Brazikumab
                
             💬
 | 
                
                    Brazikumab
                
             | [2]  96 96, 97 💬
 | 
| 5 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Risankizumab 
                
                    Risankizumab
                
             💬
 | 
                
                    Risankizumab
                
             | [4]  37 37, 96, 97, 271 💬
 | 
| 6 | 
                
                    IL23A
                
             💬
 | [9]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Mirikizumab 
                
                    Mirikizumab
                
             💬
 | 
                
                    Mirikizumab
                
             | [3]  37 37, 96, 97 💬
 |